Olema Pharmaceuticals Statistics

Total Valuation

OLMA has a market cap or net worth of $800.41 million. The enterprise value is $553.64 million.

Market Cap	800.41M
Enterprise Value	553.64M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, after market close.

Earnings Date	Aug 6, 2024
Ex-Dividend Date	n/a

Share Statistics

OLMA has 55.93 million shares outstanding. The number of shares has increased by 37.72% in one year.

Shares Outstanding	55.93M
Shares Change (YoY)	+37.72%
Shares Change (QoQ)	+22.82%
Owned by Insiders (%)	3.72%
Owned by Institutions (%)	105.70%
Float	26.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.39
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.61, with a Debt / Equity ratio of 0.01.

Current Ratio	9.61
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.90% and return on invested capital (ROIC) is -45.99%.

Return on Equity (ROE)	-42.90%
Return on Assets (ROA)	-39.30%
Return on Capital (ROIC)	-45.99%
Revenue Per Employee	n/a
Profits Per Employee	-$1.34M
Employee Count	74
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +56.57% in the last 52 weeks. The beta is 2.07, so OLMA's price volatility has been higher than the market average.

Beta (5Y)	2.07
52-Week Price Change	+56.57%
50-Day Moving Average	11.41
200-Day Moving Average	12.39
Relative Strength Index (RSI)	68.04
Average Volume (20 Days)	812,703

Short Selling Information

The latest short interest is 6.38 million, so 11.41% of the outstanding shares have been sold short.

Short Interest	6.38M
Short Previous Month	7.78M
Short % of Shares Out	11.41%
Short % of Float	24.31%
Short Ratio (days to cover)	4.50

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-109.70M
Pretax Income	-99.34M
Net Income	-99.34M
EBITDA	-97.72M
EBIT	-99.34M
Earnings Per Share (EPS)	-$2.01

Full Income Statement

Balance Sheet

The company has $248.98 million in cash and $2.21 million in debt, giving a net cash position of $246.77 million or $4.41 per share.

Cash & Cash Equivalents	248.98M
Total Debt	2.21M
Net Cash	246.77M
Net Cash Per Share	$4.41
Equity (Book Value)	236.32M
Book Value Per Share	4.22
Working Capital	225.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$86.83 million and capital expenditures -$139,000, giving a free cash flow of -$86.97 million.

Operating Cash Flow	-86.83M
Capital Expenditures	-139,000
Free Cash Flow	-86.97M
FCF Per Share	-$1.57

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OLMA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.72%
Shareholder Yield	-37.72%
Earnings Yield	-12.41%
FCF Yield	-10.87%

Analyst Forecast

The average price target for OLMA is $22.80, which is 59.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.80
Price Target Difference	59.33%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2